Utilized for male pattern hair loss to manage hormonal levels and support hair growth maintenance.
Mechanism of Action
Finasteride competitively inhibits the 5-alpha reductase enzyme, which converts testosterone to dihydrotestosterone (DHT). Lowering DHT levels in the scalp and prostate reduces hair follicle miniaturization and prostate volume.
Route of Administration
Oral
Onset Time
3–6 months
Duration
24 hours
Contraindications
Pregnancy, Use in females, Hypersensitivity to finasteride
Severe Adverse Events
Prostate cancer (high-grade), Depression, Male breast cancer — requires immediate medical attention
Common Side Effects
Erectile dysfunction, Decreased libido, Nausea
Uncommon Side Effects
Breast tenderness, Rash, Abdominal pain
Drug Interactions
Alcohol
Pregnancy Safety Warnings
FDA Category X: Strictly contraindicated. Pregnant women must not handle crushed tablets. Breastfeeding: Not applicable.
Information related to Finasteride is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
